Prot# TS011-US104: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of a Single, 1-Hour Infusion of TS-011 in Acute Ischemic Stroke (AIS) Patients

Project: Research project

Project Details

StatusFinished
Effective start/end date6/13/054/1/12

Funding

  • Omnicare Clinical Research (TS011-US104)
  • Taisho Pharmaceutical R&D Inc. (TS011-US104)